Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Nov 7, 2016 at 9:05 AM EST

Why These 2 Biopharma Companies Are Running

Shares of Ionis Pharmaceuticals and Biogen were on the move Monday morning after the companies announced positive interim results from…

Douglas A. McIntyre | Nov 7, 2016 at 8:55 AM EST

Graphic Images on Cigarette Packages Could Save 650,000 Lives

A new study published in Tobacco Control indicates that including graphic images of the effects of smoking on the printed…

Jon C. Ogg | Nov 6, 2016 at 10:20 AM EST

How Analysts View Value and Opportunity in Gilead After Earnings

If you just looked at formal Buy and Sell ratings from Wall Street analysts, you might assume that everything is…

Douglas A. McIntyre | Nov 6, 2016 at 8:12 AM EST

11 Rules That Made The NFL Safer

Playing in the NFL is still terribly dangerous, with concussions which lead to brain damage likely the worst effect on…

Chris Lange | Nov 4, 2016 at 11:45 AM EDT

Acceleron Pharma Rises Despite Q3 Revenue Miss

Acceleron Pharma released its third-quarter earnings report after the markets closed on Thursday, and shares rallied on Friday.

Chris Lange | Nov 4, 2016 at 10:05 AM EDT

Regeneron Investors Cheer Q3 Earnings Beat, Eylea Growth

Regeneron Pharmaceuticals reported mixed third-quarter financial results before the markets opened on Friday.

Chris Lange | Nov 3, 2016 at 3:33 PM EDT

Diplomat Pharmacy Tanks on Weak Earnings

Diplomat Pharmacy, Inc. (NYSE: DPLO) is one of the worst performing stocks in Thursday’s session. The company recently reported its…

Chris Lange | Nov 3, 2016 at 10:45 AM EDT

Aurinia Pharmaceuticals Jumps on Phase 3 Trial Plans

Aurinia Pharmaceuticals shares saw a handy gain on Thursday morning after the company announced plans for a late-stage trial in…

Jon C. Ogg | Nov 2, 2016 at 1:29 PM EDT

Will Any Major Insurance Companies Offer ACA/Obamacare Plans After 2017?

Trying to look at the overall impact of the Affordable Care Act, or Obamacare, is something which may depend solely…

Chris Lange | Nov 1, 2016 at 4:58 PM EDT

Has Gilead Finally Bottomed?

Gilead Sciences Inc. (NASDAQ: GILD) released third-quarter earnings report after markets closed on Tuesday. Despite negative news coming out on…

Chris Lange | Nov 1, 2016 at 11:15 AM EDT

What to Expect From Gilead Earnings

Although Gilead has been falling for about a year now, the valuation is looking more favorable — assuming Gilead is…

Chris Lange | Nov 1, 2016 at 10:35 AM EDT

Why InspireMD More Than Doubled

Shares of InspireMD more than doubled in Tuesday’s session after the company announced followup data from its Paradigm-101 trial of…

Chris Lange | Nov 1, 2016 at 10:10 AM EDT

Organovo Makes Handy Gain on Positive Consumer Response

Organovo Holdings shares saw a handy gain on Tuesday after the bio-printer announced that it received a strong consumer response…

Chris Lange | Nov 1, 2016 at 9:05 AM EDT

Why Pfizer Earnings Did Not Live Up to Expectations

As Pfizer is a major player in the pharmaceutical industry, this earnings report is important in setting a direction that…

Lee Jackson | Nov 1, 2016 at 8:35 AM EDT

Pharma Stocks Crushed Under Election Rhetoric, but Top Analysts Say Buy These 4 Now

The relentless populist rhetoric has lowered the prices on some of the top pharmaceutical companies, and long-term growth and income…

1 … 186 187 188 189 190 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why These 2 Biopharma Companies Are Running

Graphic Images on Cigarette Packages Could Save 650,000 Lives

How Analysts View Value and Opportunity in Gilead After Earnings

11 Rules That Made The NFL Safer

Acceleron Pharma Rises Despite Q3 Revenue Miss

Regeneron Investors Cheer Q3 Earnings Beat, Eylea Growth

Diplomat Pharmacy Tanks on Weak Earnings

Aurinia Pharmaceuticals Jumps on Phase 3 Trial Plans

Will Any Major Insurance Companies Offer ACA/Obamacare Plans After 2017?

Has Gilead Finally Bottomed?

What to Expect From Gilead Earnings

Why InspireMD More Than Doubled

Organovo Makes Handy Gain on Positive Consumer Response

Why Pfizer Earnings Did Not Live Up to Expectations

Pharma Stocks Crushed Under Election Rhetoric, but Top Analysts Say Buy These 4 Now

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Health and Healthcare Articles

All Health and Healthcare Articles

Why These 2 Biopharma Companies Are Running

Graphic Images on Cigarette Packages Could Save 650,000 Lives

How Analysts View Value and Opportunity in Gilead After Earnings

11 Rules That Made The NFL Safer

Acceleron Pharma Rises Despite Q3 Revenue Miss

Regeneron Investors Cheer Q3 Earnings Beat, Eylea Growth

Diplomat Pharmacy Tanks on Weak Earnings

Aurinia Pharmaceuticals Jumps on Phase 3 Trial Plans

Will Any Major Insurance Companies Offer ACA/Obamacare Plans After 2017?

Has Gilead Finally Bottomed?

What to Expect From Gilead Earnings

Why InspireMD More Than Doubled

Organovo Makes Handy Gain on Positive Consumer Response

Why Pfizer Earnings Did Not Live Up to Expectations

Pharma Stocks Crushed Under Election Rhetoric, but Top Analysts Say Buy These 4 Now

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Featured Reads

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check